Study reveals a significant link between obesity in early pregnancy and adverse pregnancy outcomes, which in turn are associated with elevated cardiovascular disease risk later in life. The findings suggest the importance of early interventions to mitigate long-term health risks.
Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.